160 related articles for article (PubMed ID: 30988740)
1. Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor.
Dai N; Zhao C; Kong Q; Li D; Cai Z; Wang M
Exp Ther Med; 2019 May; 17(5):3580-3588. PubMed ID: 30988740
[TBL] [Abstract][Full Text] [Related]
2. The Anti-inflammatory Effect of Soluble Epoxide Hydrolase Inhibitor and 14, 15-EET in Kawasaki Disease Through PPARγ/STAT1 Signaling Pathway.
Dai N; Yang C; Fan Q; Wang M; Liu X; Zhao H; Zhao C
Front Pediatr; 2020; 8():451. PubMed ID: 32903307
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid, represses human aortic smooth muscle cell proliferation and migration by regulating cell death pathways via the mTOR signaling.
Li SH; Zhao P; Tian HB; Chen LH; Cui LQ
Int J Clin Exp Pathol; 2017; 10(8):8434-8442. PubMed ID: 31966695
[TBL] [Abstract][Full Text] [Related]
6. Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury.
Hung TH; Shyue SK; Wu CH; Chen CC; Lin CC; Chang CF; Chen SF
Oncotarget; 2017 Nov; 8(61):103236-103260. PubMed ID: 29262558
[TBL] [Abstract][Full Text] [Related]
7. 14,15-Dihydroxy-eicosa-5(Z)-enoic acid selectively inhibits 14,15-epoxyeicosatrienoic acid-induced relaxations in bovine coronary arteries.
Bukhari IA; Gauthier KM; Jagadeesh SG; Sangras B; Falck JR; Campbell WB
J Pharmacol Exp Ther; 2011 Jan; 336(1):47-55. PubMed ID: 20881018
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy.
Hung YW; Hung SW; Wu YC; Wong LK; Lai MT; Shih YH; Lee TS; Lin YY
Brain Behav Immun; 2015 Jan; 43():118-29. PubMed ID: 25135858
[TBL] [Abstract][Full Text] [Related]
10. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
[TBL] [Abstract][Full Text] [Related]
11. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD
Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341
[TBL] [Abstract][Full Text] [Related]
12. Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells.
Kim HS; Kim SK; Kang KW
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232926
[TBL] [Abstract][Full Text] [Related]
13. The weakening effect of soluble epoxide hydrolase inhibitor AUDA on febrile response to lipopolysaccharide and turpentine in rat.
Piotrowski J; Jędrzejewski T; Pawlikowska M; Pacuła AJ; Ścianowski J; Kozak W
J Physiol Biochem; 2017 Nov; 73(4):551-560. PubMed ID: 28741242
[TBL] [Abstract][Full Text] [Related]
14. Increased Soluble Epoxide Hydrolase in Human Gestational Tissues from Pregnancies Complicated by Acute Chorioamnionitis.
Hung TH; Chen SF; Wu CH; Kao CC; Wu CP
Mediators Inflamm; 2019; 2019():8687120. PubMed ID: 31885501
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
[TBL] [Abstract][Full Text] [Related]
16. Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
Lee JP; Yang SH; Lee HY; Kim B; Cho JY; Paik JH; Oh YJ; Kim DK; Lim CS; Kim YS
PLoS One; 2012; 7(5):e37075. PubMed ID: 22590647
[TBL] [Abstract][Full Text] [Related]
17. The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.
Liu Y; Zhang Y; Schmelzer K; Lee TS; Fang X; Zhu Y; Spector AA; Gill S; Morisseau C; Hammock BD; Shyy JY
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16747-52. PubMed ID: 16267130
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.
Wu HF; Yen HJ; Huang CC; Lee YC; Wu SZ; Lee TS; Lin HC
J Biomed Sci; 2015 Oct; 22():94. PubMed ID: 26494028
[TBL] [Abstract][Full Text] [Related]
19. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
Dorrance AM; Rupp N; Pollock DM; Newman JW; Hammock BD; Imig JD
J Cardiovasc Pharmacol; 2005 Dec; 46(6):842-8. PubMed ID: 16306811
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
